Vaccine shortage for pandemic influenza: Can it be solved?

Vaccine

Volumn 24, Issue 15, 2006, Pages 2701-

  López, Ricardo A ^a   Zorzopulos, Jorge ^b  

^a Florida 1   (Argentina)

^b Fundacion Pablo Cassara   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; DEOXYRIBONUCLEOTIDE; IMMUNOLOGICAL ADJUVANT; IMT 504; INFLUENZA VACCINE; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIGENICITY; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; HUMAN; INFLUENZA A; INFLUENZA VIRUS A; LETTER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; OLIGODEOXYRIBONUCLEOTIDES; RATS;

EID: 33644928044     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.09.038     Document Type: Letter

References (5)

1. M. Quirk USA to manufacture two million doses of pandemic vaccine Lancet 4 2004 654
2. J.S. Nguyen-Van-Tam, and A.W. Hampson The epidemiology and clinical impact of pandemic influenza Vaccine 21 2003 1762 1768
3. T.T. Hien, M. Jong, and J. Farrar Avian influenza - a challenge to global health care structures New Eng J Med 351 2004 2363 2365
4. F. Elias, J. Flo, R.A. López, J. Zorzopulos, A. Montaner, and J.M. Rodriguez Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligonucleotides with PyNTTTTGT motifs J Immunol 171 2003 3697 3704
5. F. Elias, J. Flo, J.M. Rodríguez, A. De Nichilo, R.A. Lopez, and J. Zorzopulos PyNTTTTGT prototype oligonucleotide IMT504 is a potent adjuvant for the recombinant Hepatitis B vaccine that enhances the Th1 response Vaccine 23 2005 3597 3603